Understanding the intricacies of psoriasis and how therapies act on the disease can help to inform clinicians and their patients as they seek to make important treatment decisions. Michael Plotnick, M.D., Vice President, Global Medical Affairs, Immunology shares a research experience of his that aimed to shed some light on one nuanced aspect of psoriasis: the persistence of symptoms. Read more here.
Careers
We’re always seeking talented people who share our vision. Click here to explore opportunities in a variety of disciplines across the globe.
See More >
See More >
Leadership Blogs
Get to know our leaders. Read their unique perspectives on how they are working to change the trajectory of health.
See More >
See More >
We’re committed to showing the heart of the caregiver’s experience and providing the kind of support and information that will make a difference.
See More >
See More >
Patient Engagement
Janssen partners directly with patients and caregivers as we develop medicines, improve clinical trials, and create educational materials and support programs.
See More >
See More >
Research & Development
Our research pipeline is rich with transformational science reflecting our unique approach to innovation.
See More >
See More >
Using data science and digital health to reimagine the discovery and development of medicines to advance our mission of bringing transformative therapies to patients.
See More >
See More >
Collaborating in more than 150 markets.
By clicking on a link below, you may enter a different part of this website, or a website outside of Janssen.com.
These sections or websites are governed by their own Legal and Privacy Policies.
Global
Asia Pacific
Europe, Middle East & Africa (EMEA)
Latin America
Home › Gene Expression and Skin Clearing in Psoriasis
Gene Expression and Skin Clearing in Psoriasis
Gene Expression and Skin Clearing in Psoriasis